Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.442NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.1 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.2.5.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.600NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.12 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.525 (Eta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.6 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5.5 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.7 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.134NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.1.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.38NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.2 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
M.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5.6 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.440NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.25NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.23.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.104 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.198NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAFNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BC.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.17.1 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.375NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBHNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.78NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.9.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.64NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.221.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DP.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.62NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.82NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used